IPP Bureau

HealthPlix releases Prescription Summary Dashboard for doctors
HealthPlix releases Prescription Summary Dashboard for doctors

By IPP Bureau - December 15, 2021

Doctors can now analyse their historical prescriptions within a few clicks enabling them to identify different cohorts of patients and the treatment given to them

Aragen Life Sciences acquires Intox
Aragen Life Sciences acquires Intox

By IPP Bureau - December 15, 2021

Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune

Fullife Healthcare raises US $ 22 mn in Series C funding
Fullife Healthcare raises US $ 22 mn in Series C funding

By IPP Bureau - December 15, 2021

This round of funding will support Fast&Up and Chicnutrix to expand their domestic presence, enhance manufacturing capabilities and accelerate momentum globally

Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA
Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA

By IPP Bureau - December 15, 2021

During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests

Baxter acquires Hillrom for US $ 15 billion
Baxter acquires Hillrom for US $ 15 billion

By IPP Bureau - December 14, 2021

It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home

Moderna to set up mRNA vaccine manufacturing facility in Australia
Moderna to set up mRNA vaccine manufacturing facility in Australia

By IPP Bureau - December 14, 2021

Up to 100 million mRNA vaccine doses could be produced in Australia each year

Novartis announces next-generation CAR-T platform, T Charge
Novartis announces next-generation CAR-T platform, T Charge

By IPP Bureau - December 14, 2021

T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as the foundation for various investigational CAR-T therapies

Pfizer to acquire Arena Pharmaceuticals for US $ 6.7 bn
Pfizer to acquire Arena Pharmaceuticals for US $ 6.7 bn

By IPP Bureau - December 14, 2021

The proposed acquisition offers a potentially new, differentiated best-in-class approach to address the unmet need for a broader number of patients with immuno-inflammatory diseases

Atik Cameras launches the TE-77 advanced scientific solution
Atik Cameras launches the TE-77 advanced scientific solution

By IPP Bureau - December 14, 2021

Atik Cameras invests in new CCD sensor technology to create an advanced scientific and industrial imaging solution, using the Teledyne e2v CCD77-00 sensor

Lupin’s Goa plant receives EIR from US FDA
Lupin’s Goa plant receives EIR from US FDA

By IPP Bureau - December 14, 2021

FDA changes inspection classification of the facility to Voluntary Action Indicated

Aster brings healthcare to the doorsteps with 455 touch points
Aster brings healthcare to the doorsteps with 455 touch points

By IPP Bureau - December 14, 2021

The campaign “Care is Just An Aster Away” was launched along with the unveiling of the new corporate logo on Burj Khalifa on 11th December

Trastuzumab Deruxtecan supplemental New Drug Application for breast cancer submitted in Japan
Trastuzumab Deruxtecan supplemental New Drug Application for breast cancer submitted in Japan

By IPP Bureau - December 14, 2021

In Japan, breast cancer is the most common cancer in women, with approximately 92,000 cases of breast cancer diagnosed in 2020

Philips set to acquire Vesper Medical
Philips set to acquire Vesper Medical

By IPP Bureau - December 14, 2021

Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease

Samsung Biologics expands tie-up with AstraZeneca to include cancer therapy
Samsung Biologics expands tie-up with AstraZeneca to include cancer therapy

By IPP Bureau - December 14, 2021

The company will manufacture a cancer immunotherapy product from 2022

Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement
Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement

By IPP Bureau - December 14, 2021

Ichnos will receive an upfront payment of Euro 20.8 million as well as additional development and commercial milestone payments and tiered royalties based upon future global sales

Latest Stories

Interviews

Packaging